September 21, 2017 11:42 PM ET

Healthcare Providers and Services

Company Overview of Bio-Reference Laboratories Inc.

Company Overview

Bio-Reference Laboratories, Inc. provides clinical laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases in the United States. The company focuses on esoteric testing, molecular diagnostics, anatomical pathology, genetics, women’s health, and correctional health care services. It offers chemical diagnostic tests, such as blood and urine analysis; blood chemistry; hematology services; serology; radio-immuno analysis; toxicology, including drug screening; pap smears; tissue pathology comprising biopsies; and other tissue analysis, as well as cancer cytogenetic testing, genetic testing, and cytology testing services. The company also operate...

481 Edward H. Ross Drive

Elmwood Park, NJ 07407

United States

Founded in 1981

3,406 Employees

Phone:

201-791-2600

Key Executives for Bio-Reference Laboratories Inc.

Chief Financial Officer
Age: 58
Chief Operating Officer and Executive Vice-President
Age: 65
President of Careevolve and Chief Operating Officer of Careevolve
VP & Chief Compliance Officer
Compensation as of Fiscal Year 2017.

Bio-Reference Laboratories Inc. Key Developments

BioReference Laboratories Appoints Sandra Cole as Vice President and Chief Compliance Officer

BioReference Laboratories announced the election of Sandra Cole as its vice president and chief compliance officer. In the new senior positions, Cole will lead and oversee company-wide restructuring of compliance and privacy programmes, core compliance processes, risk assessments, metrics, analytics as well as corporate policy, with responsibility for the entire department. Prior to the promotion, Cole has served as the compliance and privacy officer at the company.

BioReference Laboratories Appoints Victoria L. Laughman as Executive Vice President of Sales

BioReference Laboratories announced the appointment of Victoria L. Laughman as Executive Vice President of Sales. With more than two decades of industry experience, including a stint at BioReference's GeneDx genetics division, Ms. Laughman will lead a national sales force from BioReference's corporate headquarters in Elmwood Park, NJ. Prior to her new post, Ms. Laughman previously served as director of physician outreach and development for the John Muir Health System in California; she was also the president and founder of Caretinuum LLC. As VP of sales, Ms. Laughman will lead a national sales force of more than 400, providing physician clients, hospitals and health systems a one-stop shop for services from routine testing to highly-specialized esoteric assays.

Diaceutics Announces Five-Year Partnership with BioReference Laboratories

Diaceutics announced five-year partnership with BioReference Laboratories. The exclusive partnership will see Diaceutics acquire real-time testing data from BioReference, allowing it to help pharmaceutical companies achieve faster rollouts of new drugs through better understanding of the US diagnostics market. Through its partnership with BioReference, which works with 30,000 healthcare providers across the US, Diaceutics will have access to data from 50,000 patient samples per day. Coupled with insights from BioReference, the real-time data will help improve patient testing by ensuring that pharmaceutical companies better understand the testing patterns of physicians considering precision medicine therapies for patients. Currently, Diaceutics estimates that pharmaceutical companies are missing out on more than 12% of cancer patients every year in the US alone due to poor diagnostic planning. With 70% of new drugs in the next five years expected to be test-dependent, Diaceutics expects that percentage will increase. Diaceutics will integrate the data gathered from BioReference with its existing data sets accumulated through partnerships with other labs. Together, the data will allow Diaceutics to provide Pharma with more complete, aggregated testing data that meets their very specific requirements and helps them close the 12% patient gap in the oncology testing market and achieve a better return on new drug investments.

Similar Private Companies By Industry

Company Name Region
@ Home Medical, Inc. United States
@home approach, llc United States
@Home Care United States
1011 E. Pecan Grove Road, LLC United States
1104 Welsh Road Operations LLC United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Tax Management Inc United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Bio-Reference Laboratories Inc., please visit www.bioreference.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.